Main > ONCOLOGY (**) > Lung>SCLC>MET > Treatment > USA. B. NivoluMAb Inj. IV Use

---

USA. B. NivoluMAb Inj. IV Use's subsections
(*) USA Approval Date: 2018. 08.17.
>one other line of therapy
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 10
Patent>UpDate: 2018. 10.16.
TradeMark
TradeMark Web-Site

USA. B. NivoluMAb Inj. IV Use's products
This section has no products